These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35513231)

  • 21. An examination of work instability, functional impairment, and disease activity in employed patients with rheumatoid arthritis.
    Macedo A; Oakley S; Gullick N; Kirkham B
    J Rheumatol; 2009 Feb; 36(2):225-30. PubMed ID: 19208557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of sustained intensive therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis: a 5-year real-world consecutive study.
    Cai YM; Li R; Ye H; He J; Sun XL; Jin JY; Liu JJ; Gan YZ; You XJ; Xu J; Shi LJ; Cheng G; Wang QW; Li ZG
    Chin Med J (Engl); 2020 Jun; 133(12):1397-1403. PubMed ID: 32496302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.
    Ruban TN; Jacob B; Pope JE; Keystone EC; Bombardier C; Kuriya B
    Clin Rheumatol; 2016 Mar; 35(3):759-63. PubMed ID: 26245721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group.
    Genitsaridi I; Flouri I; Plexousakis D; Marias K; Boki K; Skopouli F; Drosos A; Bertsias G; Boumpas D; Sidiropoulos P
    Arthritis Res Ther; 2020 Sep; 22(1):226. PubMed ID: 32993800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical conditions needed to acquire sustained functional remission in rheumatoid arthritis patients.
    Koizumi R; Koyama K; Wako M; Ohba T; Takayama Y; Haro H
    Clin Rheumatol; 2021 May; 40(5):1751-1757. PubMed ID: 33040232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy.
    Furst DE; Kavanaugh A; Florentinus S; Kupper H; Karunaratne M; Birbara CA
    Rheumatology (Oxford); 2015 Dec; 54(12):2188-97. PubMed ID: 26199453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.
    Bechman K; Tweehuysen L; Garrood T; Scott DL; Cope AP; Galloway JB; Ma MHY
    J Rheumatol; 2018 Nov; 45(11):1515-1521. PubMed ID: 30173149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register.
    Iannone F; Gremese E; Gallo G; Sarzi-Puttini P; Botsios C; Trotta F; Gasperini S; Galeazzi M; Adami S; Cantini F; Sebastiani M; Gorla R; Marchesoni A; Giardina A; Foti R; Mele A; Bruschi E; Bagnato G; Erre GL; Lapadula G;
    Clin Rheumatol; 2014 Jan; 33(1):31-7. PubMed ID: 23954923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
    Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
    Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM
    J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.
    Einarsson JT; Geborek P; Saxne T; Kristensen LE; Kapetanovic MC
    J Rheumatol; 2016 Jun; 43(6):1017-23. PubMed ID: 27036384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
    Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
    Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry.
    Guo N; Li X; Movahedi M; Cesta A; Bombardier C
    Clin Exp Rheumatol; 2024 May; 42(5):1067-1074. PubMed ID: 38372710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis.
    de Man YA; Hazes JM; van de Geijn FE; Krommenhoek C; Dolhain RJ
    Arthritis Rheum; 2007 Jun; 57(5):716-22. PubMed ID: 17530669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.
    Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M
    Value Health; 2015 Dec; 18(8):1008-15. PubMed ID: 26686785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
    Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
    Keystone E; Freundlich B; Schiff M; Li J; Hooper M
    J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients.
    Radner H; Alasti F; Smolen JS; Aletaha D
    Arthritis Res Ther; 2015 Aug; 17(1):203. PubMed ID: 26259838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity.
    Hyrich KL; Deighton C; Watson KD; ; Symmons DP; Lunt M;
    Rheumatology (Oxford); 2009 Oct; 48(10):1323-7. PubMed ID: 19706737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.